Beta-carboline derivatives show significant antitumor activity [38], and we previously demonstrated that a beta-carboline derivative DH166 inhibits the kinase activity of PLK1 in vitro, suggesting that this group of compounds may inhibit the growth of cancer cells by targeting PLK1 [32]. The gene discussed is PLK1; the disease is cancer.